Related Experiment Video
Updated: Aug 7, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
High-Sensitivity Cardiac Troponin Algorithms and the Value of Likelihood Ratios
Brett G Fischer1, Arthur T Evans2
1Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA. brf9036@med.cornell.edu.
Likelihood ratios, not predictive values, improve interpretation of high-sensitivity cardiac troponin (hs-cTn) tests for myocardial infarction diagnosis. This study provides a method to calculate likelihood ratios for better patient-centered decision-making.
Area of Science:
- Biomarker analysis
- Diagnostic accuracy
- Clinical decision-making
Background:
- High-sensitivity cardiac troponin (hs-cTn) assays are standard for non-ST-elevation myocardial infarction diagnosis.
- Current interpretation of hs-cTn results relies on predictive values, which have limited patient applicability.
- Assay-specific interpretation guidelines for hs-cTn vary, complicating clinical use.
More Related Videos
09:23Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Receiver Operating Characteristic Plot
Hazard Ratio
For example, in a clinical trial...